Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Balancing lipid synthesis and oxidation promotes B cell response to vaccination during immunosuppression
Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik, Nicole E. Skinner, Santosh Dhakal, Shuai Li, Luca Biavati, Laura A. Sena, Laila Stoddart, Karli Redinger, Samuel B. Warner, Sabra L. Klein, Nadine Rouphael, Joel N. Blankson, Yolanda Eby, Robert D. Leone, Peter S. Heeger, Mark A. Robien, Christian P. Larsen, Erika L. Pearce, Edward J. Pearce, Hongkai Ji, Andrew H. Karaba, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel, Andrea L. Cox, Justin R. Bailey
Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik, Nicole E. Skinner, Santosh Dhakal, Shuai Li, Luca Biavati, Laura A. Sena, Laila Stoddart, Karli Redinger, Samuel B. Warner, Sabra L. Klein, Nadine Rouphael, Joel N. Blankson, Yolanda Eby, Robert D. Leone, Peter S. Heeger, Mark A. Robien, Christian P. Larsen, Erika L. Pearce, Edward J. Pearce, Hongkai Ji, Andrew H. Karaba, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel, Andrea L. Cox, Justin R. Bailey
View: Text | PDF
Research Article Immunology Metabolism

Balancing lipid synthesis and oxidation promotes B cell response to vaccination during immunosuppression

  • Text
  • PDF
Abstract

Pharmacologic immunosuppression is essential for preventing organ rejection and controlling autoimmunity but profoundly impairs humoral immunity, increasing the risk of vaccine failure and infection. The mechanisms by which immunosuppressive therapies disrupt human B cell responses remain poorly defined. Here, we identified dysregulated lipid metabolism as a central determinant of impaired vaccine response in solid organ transplant recipients (SOTRs). Using high-dimensional immune profiling, single-cell transcriptomics, and functional metabolic assays, we found that effective B cell responses required a homeostatic balance between lipid synthesis and fatty acid oxidation (FAO). The widely used immunosuppressive agent mycophenolic acid (MPA) was strongly associated with vaccine nonresponses and induced excessive lipid synthesis, lipid accumulation, and mitochondrial stress in B cells. In contrast, CD11c+ B cells retained the capacity to differentiate into plasmablasts in the presence of MPA through elevated expression of CPT1a, a mitochondrial FA transporter, and enhanced FAO. These cells were found to be a key feature of early effective vaccine responses in healthy individuals and SOTRs. Notably, pharmacologic inhibition of cholesterol synthesis partially restored plasmablast differentiation in the presence of MPA. These findings identify B cell lipid metabolism as a critical and targetable regulator of human humoral immunity during immunosuppression.

Authors

Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik, Nicole E. Skinner, Santosh Dhakal, Shuai Li, Luca Biavati, Laura A. Sena, Laila Stoddart, Karli Redinger, Samuel B. Warner, Sabra L. Klein, Nadine Rouphael, Joel N. Blankson, Yolanda Eby, Robert D. Leone, Peter S. Heeger, Mark A. Robien, Christian P. Larsen, Erika L. Pearce, Edward J. Pearce, Hongkai Ji, Andrew H. Karaba, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel, Andrea L. Cox, Justin R. Bailey

×

Figure 5

CPT1a+CD11c+ B cells are associated with vaccine responses in SOTRs.

Options: View larger image (or click on image) Download as PowerPoint
CPT1a+CD11c+ B cells are associated with vaccine responses in SOTRs.
(A)...
(A) Concatenated flow cytometric data depicted as UMAP of CD19+ B cells colored by cluster annotation, as determined by FlowSOM using data collected from a subset of the observational cohort before and 2 weeks after D3 (n = 10 HCs, n = 4 nonresponders [NR], n = 17 responders [R]). (B) Frequency of FlowSOM clusters segregated by response. (C) Heatmap depicting mean scaled expression of all markers annotated by FlowSOM cluster. (D) Normalized expression of CPT1a (MFI) on total CD11c– or CD11c+ B cells. (E) Concatenated files demonstrating identification of cluster 3 B cells and CD11c+ B cells and the correlation between cells. Correlation tested using Spearman correlation. (F) B cells were gated as total CD19+ B cells, cluster 3+ B cells, or CD11c+ B cells. Pie charts depict the percentage of subsets within total (left), cluster 3 (middle), and CD11c+ B cells (right). Arcs depict higher-level annotations (see Supplemental Figure 7, A and B, for the gating scheme). (G and H) Frequency of CD11c+ B cells out of total B cells (G) or S-specific B cells (H) from combined cohorts (see Supplemental Figure 7, C–E for individual cohorts). (I and J) Additional samples were evaluated for the frequency of CD11c+ B cells among total B cells or S-specific B cells compared with anti–S IgG titers in HCs and SOTRs. Data are segregated by the peak response (≤30 days after D3) or waning response (>30 days after D3). Data are presented as the mean ± SEM. Significance was tested using Kruskal-Wallis test (B, D, G, and H). Correlation was tested using Spearman’s correlation (E). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts